共 5 条
[1]
Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies
[J].
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY,
2019, 20 (01)
:155-164
[2]
Badia X, 1999, BRIT J DERMATOL, V141, P698